China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.05 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ITOS I Teos Therapeutics, Inc.	$360M	$43,000 0.0% of portfolio	7,328	Q1 2025 Reduced 5.41%
DSGN Design Therapeutics, Inc.	$237M	$43,000 0.0% of portfolio	11,357	Q1 2025 Reduced 5.41%
ANNX Annexon, Inc.	$114M	$41,000 0.0% of portfolio	21,381	Q1 2025 Reduced 5.4%
CRVS Corvus Pharmaceuticals, Inc.	$209M	$40,000 0.0% of portfolio	12,889	Q1 2025 Reduced 5.4%
FHTX Foghorn Therapeutics Inc.	$264M	$40,000 0.0% of portfolio	11,155	Q1 2025 Reduced 5.37%
YMAB Y M Abs Therapeutics, Inc.	$193M	$39,000 0.0% of portfolio	8,984	Q1 2025 Reduced 5.4%
ACIU Ac Immune Sa	$193M	$37,000 0.0% of portfolio	19,837	Q1 2025 Reduced 5.4%
VYGR Voyager Therapeutics, Inc.	$122M	$37,000 0.0% of portfolio	10,957	Q1 2025 Reduced 5.4%
LXRX Lexicon Pharmaceuticals, Inc.	$226M	$33,000 0.0% of portfolio	72,509	Q1 2025 Reduced 5.4%
LYEL Lyell Immunopharma, Inc.	$2.55B	$31,000 0.0% of portfolio	58,603	Q1 2025 Reduced 1.02%
THRD Third Harmonic Bio, Inc.	$219M	$31,000 0.0% of portfolio	9,038	Q1 2025 Reduced 5.4%
TNGX Tango Therapeutics, Inc.	$588M	$29,000 0.0% of portfolio	21,685	Q1 2025 Reduced 4.79%
FDMT 4 D Molecular Therapeutics, Inc.	$146M	$29,000 0.0% of portfolio	9,287	Q1 2025 Reduced 5.25%
LRMR Larimar Therapeutics, Inc.	$149M	$27,000 0.0% of portfolio	12,799	Q1 2025 Reduced 5.4%
SLN Silence Therapeutics PLC	$224M	$26,000 0.0% of portfolio	9,432	Q1 2025 Reduced 5.33%
SCPH Sc Pharmaceuticals Inc.	$147M	$26,000 0.0% of portfolio	10,037	Q1 2025 Reduced 5.4%
NKTX Nkarta, Inc.	$101M	$26,000 0.0% of portfolio	14,155	Q1 2025 Reduced 5.4%
ALEC Alector, Inc.	$142M	$24,000 0.0% of portfolio	19,875	Q1 2025 Reduced 4.29%
ENTA Enanta Pharmaceuticals Inc	$159M	$23,000 0.0% of portfolio	4,279	Q1 2025 Reduced 4.78%
CCCC C4 Therapeutics, Inc.	$109M	$22,000 0.0% of portfolio	14,239	Q1 2025 Reduced 4.86%
EDIT Editas Medicine, Inc.	$231M	$19,000 0.0% of portfolio	16,558	Q1 2025 Reduced 5.4%
FATE Fate Therapeutics Inc	$120M	$18,000 0.0% of portfolio	22,845	Q1 2025 Reduced 5.4%
PLRX Pliant Therapeutics, Inc.	$76.4M	$16,000 0.0% of portfolio	12,206	Q1 2025 Reduced 5.4%
MGNX Macrogenics Inc	$94.6M	$15,000 0.0% of portfolio	12,589	Q1 2025 Reduced 5.4%
BMEA Biomea Fusion, Inc.	$53.3M	$15,000 0.0% of portfolio	7,269	Q1 2025 Reduced 5.4%
TCRX T Scan Therapeutics, Inc.	$34.8M	$13,000 0.0% of portfolio	9,847	Q1 2025 Reduced 5.41%
INZY Inozyme Pharma, Inc.	$161M	$11,000 0.0% of portfolio	12,885	Q1 2025 Reduced 5.4%
PYXS Pyxis Oncology, Inc.	$40M	$11,000 0.0% of portfolio	11,928	Q1 2025 Reduced 5.4%
APLT Applied Therapeutics Inc.	$22.1M	$11,000 0.0% of portfolio	23,339	Q1 2025 Reduced 5.4%
STRO Sutro Biopharma, Inc.	$44.9M	$10,000 0.0% of portfolio	16,540	Q1 2025 Reduced 5.4%
PEPG Pep Gen Inc.	$33.1M	$9,000 0.0% of portfolio	6,558	Q1 2025 Reduced 5.11%
MRSN Mersana Therapeutics, Inc.	$35M	$8,000 0.0% of portfolio	24,779	Q1 2025 Reduced 5.4%
IGMS Igm Biosciences, Inc.	$36.8M	$7,000 0.0% of portfolio	6,835	Q1 2025 Reduced 5.41%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	19,494	Q1 2025 Reduced 5.4%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.